COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib (DasPAQT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02348957
Recruitment Status : Completed
First Posted : January 28, 2015
Last Update Posted : July 25, 2019
Information provided by (Responsible Party):
Onco Medical Consult GmbH

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2019
Actual Study Completion Date : May 2019